Critical equipment qualification parameters affecting the homogenization process of medical cannabis semi-solid pharmaceuticals

Cocovska, Ivana and Janevik-Ivanovska, Emilija (2022) Critical equipment qualification parameters affecting the homogenization process of medical cannabis semi-solid pharmaceuticals. Knowledge - International Journal, 54 (4). pp. 669-675. ISSN 2545-4439

	Text 8. Ivana Cocovska - CRITICAL EQUIPMENT QUALIFICATION PARAMETERS AFFECTING THE HOMOGENIZATION PROCESS OF MEDICAL .pdf Download (419kB)
	Text 5545 - Published Version Download (4kB)

Abstract

The medical cannabis has been used for many of years for medicinal purpose, in different pharmaceutical formulation, mostly as a magistral preparation for the relief of pain in cancer patients or chronical painful diseases. Over than 540 substances were found from which more than 100 that have been found to be cannabinoids due to their similar chemical structure. The component with the most psychotropic action is Δ9 -tetrahydrocannabinol (Δ9 -THC), and the major non-psychoactive ingredient is cannabidiol (CBD). Δ9 -tetrahydrocannabinol firstly was isolated in 1969 by Robert Mechoulm and Yechiel Gaoni. In 2003 World Health Organization put Δ9 -tetrahydrocannabinol in Schedule IV of the convention. Several therapeutic indications relate to the Δ9 -THC and CBD as analgesia, inflammatory and neurodegenerative diseases, and many other cases. In some studies, there are reported safety concerns about the registered side effects of Δ9 -THC as a psychoactive. For that reason, the legal usage of cannabis for medicinal purposes and for recreational use is regulated differently. The most relevant explanation isrelated to the not enough sufficient results and data obtained from the pharmacokinetic studies and research in pharmacological behavior. Extracts of cannabis was used from many years ago. Nowadays in pharmaceutical industry as the development of technology there are many dosage forms in where extracts, cannabinoids, flower are used. Medicinal cannabis products can come in many different forms, including capsules, drops, chewable, creams, crystals, flower, lozenges, oil (most common), oro-mucosal sprays, tinctures and many more. Also, there are synthetic analogs to nature cannabinoids in pharmaceutical market. In this study will be discussed about production of semisolid pharmaceutical forms obtained from medical cannabis. They are produced in pharmaceutical grade equipment, high-pressure homogenizer mixer. In this study it will be discussed about the process of equipment qualification. Firstly, by the user requirement specification, design qualification protocol was approved. Then factory acceptance test was performed in production site of equipment and site acceptance test was performed in costumer’s site. Then installation qualification protocol was look through and then operational qualification protocol also. All the qualification protocols were approvedby both sides. In different qualification protocols, different tests were performed, and they are explained separately. During the qualification process,there are considered some of the parameters which later during the production process can affect in the quality of finished products. These parameters are called critical process parameters and accent will be put on this process parameters that are with a critical effect on quality of the final products. This critical process parameters were considered and concluded from qualification protocols where all the parameters that can affect quality of the product were separately examine.

Item Type:	Article
Subjects:	Medical and Health Sciences > Health biotechnology Medical and Health Sciences > Health sciences Medical and Health Sciences > Other medical sciences
Divisions:	Faculty of Medical Science
Depositing User:	Emilija Janevik
Date Deposited:	04 Feb 2023 21:41
Last Modified:	04 Feb 2023 21:41
URI:	https://eprints.ugd.edu.mk/id/eprint/31315

Actions (login required)

View Item